Year: 2021

news_6

IASO Receives NMPA Acceptance of its First Indication IND Application for CT120, a Fully Human CD19/CD22 Dual-Targeting CAR-T Therapy

PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#Biopharmaceutical--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in the discovery and development of...

news_6

World Electric Bus (BEV, PHEV & FCEV) Market Report 2021-2027: New Revenue Pockets in Asia-Pacific and Northern Europe – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Electric Bus Market by Propulsion (BEV, PHEV & FCEV), Application (Intercity & Intra-city), Consumer Segment (Fleet Operators &...